Growth Metrics

Silence Therapeutics (SLN) Goodwill (2019 - 2025)

Historic Goodwill for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $10.6 million.

  • Silence Therapeutics' Goodwill rose 1298.98% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 1298.98%. This contributed to the annual value of $9.4 million for FY2024, which is 590.12% down from last year.
  • Per Silence Therapeutics' latest filing, its Goodwill stood at $10.6 million for Q3 2025, which was up 1298.98% from $10.6 million recorded in Q2 2025.
  • Silence Therapeutics' 5-year Goodwill high stood at $10.9 million for Q2 2021, and its period low was $9.4 million during Q3 2022.
  • Its 5-year average for Goodwill is $9.9 million, with a median of $9.8 million in 2024.
  • In the last 5 years, Silence Therapeutics' Goodwill plummeted by 1262.16% in 2022 and then surged by 1298.98% in 2025.
  • Over the past 5 years, Silence Therapeutics' Goodwill (Quarter) stood at $10.2 million in 2021, then decreased by 8.21% to $9.4 million in 2022, then increased by 3.58% to $9.7 million in 2023, then fell by 3.48% to $9.4 million in 2024, then increased by 12.99% to $10.6 million in 2025.
  • Its Goodwill stands at $10.6 million for Q3 2025, versus $10.6 million for Q2 2025 and $9.8 million for Q1 2025.